Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

Circulating or cell-free DNA (cfDNA) has been evaluated as a biomarker in many cancers including breast cancer. In particular, integrity of cfDNA has been shown to be altered in cancers. We have estimated the biomarker potential of cfDNA in primary (PBC) and metastatic breast cancer (MBC). cfDNA int...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Madhavan, Dharanija (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Zucknick, Manuela (VerfasserIn) , Nees, Juliane (VerfasserIn) , Schott, Sarah (VerfasserIn) , Cuk, Katarina (VerfasserIn) , Trumpp, Andreas (VerfasserIn) , Sohn, Christof (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Surowy, Harald (VerfasserIn) , Burwinkel, Barbara (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 May 2014
In: Breast cancer research and treatment
Year: 2014, Jahrgang: 146, Heft: 1, Pages: 163-174
ISSN:1573-7217
DOI:10.1007/s10549-014-2946-2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s10549-014-2946-2
Volltext
Verfasserangaben:Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, Barbara Burwinkel

MARC

LEADER 00000caa a2200000 c 4500
001 1727597451
003 DE-627
005 20240406193248.0
007 cr uuu---uuuuu
008 200821s2014 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10549-014-2946-2  |2 doi 
035 |a (DE-627)1727597451 
035 |a (DE-599)KXP1727597451 
035 |a (OCoLC)1341357315 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Madhavan, Dharanija  |d 1986-  |e VerfasserIn  |0 (DE-588)1064644856  |0 (DE-627)813661781  |0 (DE-576)424001519  |4 aut 
245 1 0 |a Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis  |c Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, Barbara Burwinkel 
264 1 |c 17 May 2014 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am TT.MM.JJJ 
520 |a Circulating or cell-free DNA (cfDNA) has been evaluated as a biomarker in many cancers including breast cancer. In particular, integrity of cfDNA has been shown to be altered in cancers. We have estimated the biomarker potential of cfDNA in primary (PBC) and metastatic breast cancer (MBC). cfDNA integrity (cfDI) and concentration were determined in plasma of 383 individuals, including 82 PBC and 201 MBC cases, as well as 100 healthy controls, by measuring ALU and LINE1 repetitive DNA elements using quantitative PCR. The MBC patient group was further sub-divided into patients with detectable circulating tumour cells (CTCpos-MBC, n = 100) and those without (CTCneg-MBC, n = 101). A hierarchical decrease in cfDI and increase in cfDNA concentration from healthy controls to PBC and further onto MBC patients were observed. Investigation of cfDNA in media of cell lines was in concordance with these results. Combination of cfDI and cfDNA concentration could differentiate PBC cases from controls (area under the curve, AUC = 0.75), MBC cases from controls (AUC = 0.81 for CTCneg-MBC, AUC = 0.93 for CTCpos-MBC), and CTCneg-MBC from CTCpos-MBC cases (AUC = 0.83). cfDI additionally demonstrated a positive correlation to progression-free (HR of 0.46 for ALU, P = 0.0025) and overall survival (HR of 0.15 for ALU and 0.20 for LINE1, P < 0.0001) in MBC, and had lower prediction error than CTC status. Our findings show that reduced cfDI and increased cfDNA concentration can serve as diagnostic markers for PBC and MBC, and cfDI as a prognostic marker for MBC, thereby making them attractive candidates for blood-based multi-marker assays. 
700 1 |a Wallwiener, Markus  |d 1980-  |e VerfasserIn  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 aut 
700 1 |a Zucknick, Manuela  |e VerfasserIn  |0 (DE-588)1211103323  |0 (DE-627)1698942583  |4 aut 
700 1 |a Nees, Juliane  |d 1989-  |e VerfasserIn  |0 (DE-588)108222295X  |0 (DE-627)84721270X  |0 (DE-576)455206988  |4 aut 
700 1 |a Schott, Sarah  |d 1981-  |e VerfasserIn  |0 (DE-588)133730816  |0 (DE-627)552697281  |0 (DE-576)27460678X  |4 aut 
700 1 |a Cuk, Katarina  |d 1985-  |e VerfasserIn  |0 (DE-588)1046823701  |0 (DE-627)777096609  |0 (DE-576)400153750  |4 aut 
700 1 |a Trumpp, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)1081774134  |0 (DE-627)846650266  |0 (DE-576)454773552  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Surowy, Harald  |d 1981-  |e VerfasserIn  |0 (DE-588)1019526955  |0 (DE-627)685053768  |0 (DE-576)35825003X  |4 aut 
700 1 |a Burwinkel, Barbara  |d 1969-  |e VerfasserIn  |0 (DE-588)120685760  |0 (DE-627)704924005  |0 (DE-576)292337752  |4 aut 
773 0 8 |i Enthalten in  |t Breast cancer research and treatment  |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981  |g 146(2014), 1, Seite 163-174  |h Online-Ressource  |w (DE-627)320433722  |w (DE-600)2004077-5  |w (DE-576)104194162  |x 1573-7217  |7 nnas  |a Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis 
773 1 8 |g volume:146  |g year:2014  |g number:1  |g pages:163-174  |g extent:12  |a Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis 
856 4 0 |u https://doi.org/10.1007/s10549-014-2946-2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200821 
993 |a Article 
994 |a 2014 
998 |g 120685760  |a Burwinkel, Barbara  |m 120685760:Burwinkel, Barbara  |d 910000  |d 910400  |e 910000PB120685760  |e 910400PB120685760  |k 0/910000/  |k 1/910000/910400/  |p 14  |y j 
998 |g 1019526955  |a Surowy, Harald  |m 1019526955:Surowy, Harald  |d 50000  |e 50000PS1019526955  |k 0/50000/  |p 13 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 12 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 11 
998 |g 1081774134  |a Trumpp, Andreas  |m 1081774134:Trumpp, Andreas  |p 9 
998 |g 1046823701  |a Cuk, Katarina  |m 1046823701:Cuk, Katarina  |d 50000  |e 50000PC1046823701  |k 0/50000/  |p 7 
998 |g 133730816  |a Schott, Sarah  |m 133730816:Schott, Sarah  |d 910000  |d 910400  |e 910000PS133730816  |e 910400PS133730816  |k 0/910000/  |k 1/910000/910400/  |p 6 
998 |g 108222295X  |a Nees, Juliane  |m 108222295X:Nees, Juliane  |d 910000  |d 910400  |e 910000PN108222295X  |e 910400PN108222295X  |k 0/910000/  |k 1/910000/910400/  |p 5 
998 |g 1211103323  |a Zucknick, Manuela  |m 1211103323:Zucknick, Manuela  |d 50000  |e 50000PZ1211103323  |k 0/50000/  |p 4 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |e 910000PW134044827  |e 910400PW134044827  |k 0/910000/  |k 1/910000/910400/  |p 2 
998 |g 1064644856  |a Madhavan, Dharanija  |m 1064644856:Madhavan, Dharanija  |d 50000  |e 50000PM1064644856  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1727597451  |e 3741613851 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Madhavan, Dharanija","given":"Dharanija","role":"aut","family":"Madhavan"},{"role":"aut","family":"Wallwiener","display":"Wallwiener, Markus","given":"Markus"},{"family":"Zucknick","role":"aut","given":"Manuela","display":"Zucknick, Manuela"},{"display":"Nees, Juliane","given":"Juliane","family":"Nees","role":"aut"},{"role":"aut","family":"Schott","display":"Schott, Sarah","given":"Sarah"},{"role":"aut","family":"Cuk","given":"Katarina","display":"Cuk, Katarina"},{"display":"Trumpp, Andreas","given":"Andreas","role":"aut","family":"Trumpp"},{"given":"Christof","display":"Sohn, Christof","role":"aut","family":"Sohn"},{"family":"Schneeweiss","role":"aut","display":"Schneeweiss, Andreas","given":"Andreas"},{"display":"Surowy, Harald","given":"Harald","role":"aut","family":"Surowy"},{"display":"Burwinkel, Barbara","given":"Barbara","family":"Burwinkel","role":"aut"}],"recId":"1727597451","note":["Gesehen am TT.MM.JJJ"],"name":{"displayForm":["Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, Barbara Burwinkel"]},"language":["eng"],"relHost":[{"recId":"320433722","title":[{"title_sort":"Breast cancer research and treatment","title":"Breast cancer research and treatment"}],"id":{"zdb":["2004077-5"],"eki":["320433722"],"issn":["1573-7217"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Springer Science + Business Media B.V. ; Kluwer","dateIssuedDisp":"1981-","dateIssuedKey":"1981","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}],"language":["eng"],"part":{"volume":"146","year":"2014","issue":"1","pages":"163-174","extent":"12","text":"146(2014), 1, Seite 163-174"},"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1981 -"],"disp":"Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosisBreast cancer research and treatment","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"17 May 2014","dateIssuedKey":"2014"}],"title":[{"title_sort":"Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis","title":"Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S."}],"id":{"eki":["1727597451"],"doi":["10.1007/s10549-014-2946-2"]}} 
SRT |a MADHAVANDHPLASMADNAI1720